<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7383122\results\search\drug\results.xml">
  <result pre="Based on in vitro data and a controversial recent trial," exact="hydroxychloroquine" post="has gained widespread adoption as part of institutional protocols"/>
  <result pre="institutional protocols to manage the COVID-19 infection [49, 50]. Both" exact="chloroquine" post="and hydroxychloroquine block a potassium channel that can prolong"/>
  <result pre="to manage the COVID-19 infection [49, 50]. Both chloroquine and" exact="hydroxychloroquine" post="block a potassium channel that can prolong the QTc"/>
  <result pre="with the other currently suggested treatments including the QTc prolonging" exact="azithromycin" post="and lopinavir/ritonavir (all three medications are on CredibleMeds QTc"/>
  <result pre="Suggested COVID-19 medication Potential HF and transplant patient medication Interaction" exact="Hydroxychloroquine" post="Beta blockers Hydroxychloroquine inhibits CYP2D6 increasing beta blocker concentration"/>
  <result pre="Potential HF and transplant patient medication Interaction Hydroxychloroquine Beta blockers" exact="Hydroxychloroquine" post="inhibits CYP2D6 increasing beta blocker concentration âž&quot; monitor for"/>
  <result pre="(amiodarone, dofetilide) Higher risk of QTc prolongation and TdP Cyclosporine" exact="Hydroxychloroquine" post="may increase serum concentration of cyclosporine through unknown mechanisms"/>
  <result pre="prolongation and TdP Cyclosporine Hydroxychloroquine may increase serum concentration of" exact="cyclosporine" post="through unknown mechanisms Digoxin Hydroxychloroquine may inhibit p-glycoprotein-mediated digoxin"/>
  <result pre="Hydroxychloroquine may increase serum concentration of cyclosporine through unknown mechanisms" exact="Digoxin" post="Hydroxychloroquine may inhibit p-glycoprotein-mediated digoxin transport âž&quot; may increase"/>
  <result pre="may increase serum concentration of cyclosporine through unknown mechanisms Digoxin" exact="Hydroxychloroquine" post="may inhibit p-glycoprotein-mediated digoxin transport âž&quot; may increase digoxin"/>
  <result pre="of cyclosporine through unknown mechanisms Digoxin Hydroxychloroquine may inhibit p-glycoprotein-mediated" exact="digoxin" post="transport âž&quot; may increase digoxin concentration Lopinavir/ritonavir (Lpv/R) Antiarrhythmic"/>
  <result pre="Digoxin Hydroxychloroquine may inhibit p-glycoprotein-mediated digoxin transport âž&quot; may increase" exact="digoxin" post="concentration Lopinavir/ritonavir (Lpv/R) Antiarrhythmic medications (amiodarone, dofetilide) Lpv/R inhibits"/>
  <result pre="âž&quot; increase in antiarrhythmic concentration, side effects, and QTc prolongation" exact="Eplerenone" post="Lpv/R inhibits CYP3A4 âž&quot; increase in concentration of eplerenone"/>
  <result pre="Eplerenone Lpv/R inhibits CYP3A4 âž&quot; increase in concentration of eplerenone" exact="Ivabradine" post="Lpv/R inhibits CYP3A4 âž&quot; increase in concentration of ivabradine"/>
  <result pre="eplerenone Ivabradine Lpv/R inhibits CYP3A4 âž&quot; increase in concentration of" exact="ivabradine" post="Cyclosporine Lpv/R inhibits CYP3A4 âž&quot; increase in concentration of"/>
  <result pre="ivabradine Cyclosporine Lpv/R inhibits CYP3A4 âž&quot; increase in concentration of" exact="tacrolimus" post="Tacrolimus Lpv/R inhibits CYP3A4 âž&quot; increase in concentration of"/>
  <result pre="Cyclosporine Lpv/R inhibits CYP3A4 âž&quot; increase in concentration of tacrolimus" exact="Tacrolimus" post="Lpv/R inhibits CYP3A4 âž&quot; increase in concentration of tacrolimus"/>
  <result pre="tacrolimus Tacrolimus Lpv/R inhibits CYP3A4 âž&quot; increase in concentration of" exact="tacrolimus" post="Warfarin (VKA) Lpv/R may decrease VKA concentration through induction"/>
  <result pre="Tacrolimus Lpv/R inhibits CYP3A4 âž&quot; increase in concentration of tacrolimus" exact="Warfarin" post="(VKA) Lpv/R may decrease VKA concentration through induction of"/>
  <result pre="Lung Transplantation (ISHLT) guidelines suggest holding the immunosuppressive drugs like" exact="mycophenolate mofetil" post="or azathioprine in moderate to severe presentations of COVID-19"/>
  <result pre="guidelines suggest holding the immunosuppressive drugs like mycophenolate mofetil or" exact="azathioprine" post="in moderate to severe presentations of COVID-19 [69]. For"/>
  <result pre="mortality in Covid-19. N Engl J Med 382(25):e102. 10.1056/NEJMoa2007621 7.NgTMToewsMLImpaired" exact="norepinephrine" post="regulation of monocyte inflammatory cytokine balance in heart failureWorld"/>
  <result pre="2020. Available from: https://www.acc.org/latest-in-cardiology/articles/2020/03/17/08/59/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19. Accessed 27 Apr 2020 49.WangMCaoRZhangLYangXLiuJXuMShiZHuZZhongWXiaoGRemdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="J, Giordanengo V, Vieira VE, Dupont HT, HonorÃ© S (2020)" exact="Hydroxychloroquine" post="and azithromycin as a treatment of COVID-19: results of"/>
  <result pre="V, Vieira VE, Dupont HT, HonorÃ© S (2020) Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
  <result pre="products on P-glycoprotein mediated effluxEur J Pharm Sci2006291708116846720 56.SomerMKallioJPesonenUPyykkÃ¶KHuupponenRScheininMInfluence of" exact="hydroxychloroquine" post="on the bioavailability of oral metoprololBr J Clin Pharmacol200049654955410848718"/>
 </snippets>
</snippetsTree>
